Prospective, Multicenter, Investigation of the Adagio Cryoablation System in Subjects With Atrial Flutter

NCT02355106 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17

Last updated 2019-05-22

No results posted yet for this study

Summary

The objective of the study is to demonstrate the safety and feasibility of the Adagio System in subjects with Atrial Flutter.

Conditions

  • Atrial Flutter

Interventions

DEVICE

PolarStart System

Atrial flutter Ablation

Sponsors & Collaborators

  • Adagio Medical

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2019-05-01
Completion
2019-05-21

Countries

  • Belgium
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02355106 on ClinicalTrials.gov